AlphaCore Capital’s ResMed RMD Stock Holding History

AlphaCore Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-971	Closed	-$234K	–	1456
2025 Q4	$234K	Buy	+971	New	+$248K	0.01%	914
2025 Q3	–	Sell	-423	Closed	-$109K	–	1122
2025 Q2	$109K	Buy	+423	New	+$101K	﹤0.01%	695

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AlphaCore Capital's RMD Position: Q1 2026 in Review

AlphaCore Capital sold out of ResMed (RMD) in Q1 2026, closing a stake of 971 shares — an estimated $234K sold.

AlphaCore Capital first reported a position in RMD in Q2 2025 and held it in 2 quarters. The position peaked at $234K in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

AlphaCore Capital reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
AlphaCore Capital sold 971 ResMed shares in Q1 2026, an estimated $234K.
AlphaCore Capital first reported a position in ResMed in Q2 2025 and held it in 2 quarters.
AlphaCore Capital's ResMed position peaked at $234K in Q4 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.